Medidata Solutions Schedules Third Quarter Earnings Conference Call for November 12, 2009
More News related to MDSO
- Medidata Solutions (MDSO) Announces 4.5M Common Offering by Selling Shareholders
- Medidata Solutions Files Registration Statement for Public Offering of Common Stock
- After-Hours Movers 11/12: TSTC, LXRX, MDSO Higher; DISK, MRNA, LIME, BBI, ESE, JWN Lower
- Medidata Solutions (MDSO) Tops Q3 Views; Guides Q4, FY09
- Medidata Solutions Reports Record Third Quarter 2009 Results
More News related to Press Releases
- Gold Higher On Reports India Could Buy the Rest of the IMF's Hoard (GLD)
- Vietnam Devalues Currency, Hikes Rates
- Deere & Company (DE) Posts Q4 EPS of $0.20, Handily Tops Estimates; Guides FY10 Earnings
- Tiffany & Co. (TIF) Posts Q3 EPS of $0.33 Ex-Items, Beats by 9c; Guides EPS Higher
- Incyte (INCY) In License Agreement With Novartis, Worth Up to $1 Billion
NEW YORK--(BUSINESS WIRE)-- Medidata Solutions (Nasdaq: MDSO), a leading global provider of hosted clinical development solutions, today announced that it will release its third quarter 2009 financial results following the close of the market on Thursday, November 12, 2009. Tarek Sherif, chief executive officer, and Bruce Dalziel, chief financial officer, will also hold a conference call at 5:00 p.m. ET for investors and analysts to review these results and discuss the outlook for the fourth quarter and full year 2009.
To participate by telephone, domestic participants may dial 888-378-0337 and international participants may dial 719-325-2173. Those interested in participating in the conference call should dial in at least 10 minutes prior to the call to register.
Participants can also join the call via a simultaneous live audio webcast, which will be made available on the "Investor" section of Medidata's Web site, http://investor.mdsol.com/.
A replay of the conference call can be accessed until Thursday, November 26, 2009 by dialing 888-203-1112 domestically or 719-457-0820 internationally, with the passcode 6391430. An archive of the call will also be hosted on the "Investor" section of Medidata's Web site, http://investor.mdsol.com/, for a limited period of time.
About Medidata Solutions Worldwide
Medidata Solutions (www.mdsol.com) is a leading global provider of hosted clinical development solutions that enhance the efficiency of customers' clinical development processes and optimize their research and development investments. Medidata products and services allow customers to achieve clinical results more efficiently and effectively by streamlining the design, planning and management of key aspects of the clinical development process, including protocol development (Medidata Designer(R)), investigator benchmarking and budgeting (Medidata Grants Manager(TM)), contract research organization (CRO) benchmarking and budgeting (Medidata CRO Contractor(TM)), and the capture, management, analysis and reporting of clinical trial data (Medidata Rave(R)). Medidata's diverse customer base spans pharmaceutical, biotechnology and medical device companies, academic institutions, CROs and other research organizations, and includes more than 20 of the top 25 global pharmaceutical companies.
Source: Medidata Solutions
Related Categories
Press ReleasesStocks Mentioned
-0.09Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
